Extreme body mass index and survival in newly diagnosed multiple myeloma patients

Blood Cancer J. 2023 Jan 12;13(1):13. doi: 10.1038/s41408-022-00782-7.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Body Mass Index
  • Bortezomib
  • Humans
  • Multiple Myeloma* / diagnosis
  • Treatment Outcome

Substances

  • Bortezomib